國立虎尾科技大學 |

Hodgkin Lymphoma = A Comprehensive Overview /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Hodgkin Lymphoma/ edited by Andreas Engert, Anas Younes.
Reminder of title:	A Comprehensive Overview /
other author:	Engert, Andreas.
Description:	IX, 509 p. 102 illus., 83 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Hematology. -
Online resource:	https://doi.org/10.1007/978-3-030-32482-7
ISBN:	9783030324827

Hodgkin Lymphoma = A Comprehensive Overview /
Hodgkin LymphomaA Comprehensive Overview /[electronic resource] :edited by Andreas Engert, Anas Younes. - 3rd ed. 2020. - IX, 509 p. 102 illus., 83 illus. in color.online resource. - Hematologic Malignancies,2197-9766. - Hematologic Malignancies,.

Part I: Epidemiology and Pathogenesis -- Epidemiology of Hodgkin Lymphoma -- The role of viruses in the genesis of Hodgkin Lymphoma -- Pathology and molecular pathology of Hodgkin Lymphoma -- Microenvironment, cross-talk and immune escape mechanisms.-What will we learn from Genomics and Proteomics in Hodgkin Lymphoma? -- Part II: Diagnosis and first-line treatment -- Clinical evaluation -- Functional imaging in Hodgkin Lymphoma -- Prognostic factors. - Principles of Radiation Therapy for Hodgkin Lymphoma -- Principles of chemotherapy in Hodgkin Lymphoma -- Treatment of early favorable Hodgkin Lymphoma -- Treatment of early unfavorable Hodgkin Lymphoma -- Treatment of advanced-stage Hodgkin Lymphoma -- Optimizing Decision Making in HL -- Part III: Special clinical situations -- Paediatric/adolescent Hodgkin Lymphoma -- The management of elderly patients with Hodgkin Lymphoma -- Nodular Lymphocyte-Predominant Hodgkin Lymphoma -- The management of Hodgkin Lymphoma during pregnancy -- The management of HIV-Hodgkin Lymphoma -- Part IV: Relapsed and refractory disease -- Relapsed and refractory Hodgkin Lymphoma -- Allogeneic transplantation for relapsed Hodgkin Lymphoma -- Targeting CD30 in Patients with Hodgkin Lymphoma -- Hodgkin Lymphoma and PD-1 blockade -- Other new agents for Hodgkin Lymphoma -- Part V: Survivorship -- Quality of Life in Hodgkin lymphoma -- Second malignancy risk after treatment of Hodgkin Lymphoma -- Cardiovascular and pulmonary late effects -- Gonadal dysfunction and fertility preservation in Hodgkin Lymphoma patients -- Fatigue.

This book, now in its third edition, examines the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the appropriate management in special clinical circumstances, including in the elderly, pregnant women, and those with nodular lymphocyte-predominant disease (NLPHL). Careful attention is devoted to the emerging individually tailored treatment strategies, including checkpoint inhibition, that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The new edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by key opinion leaders to reflect recent progress in the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma.

ISBN: 9783030324827

Standard No.: 10.1007/978-3-030-32482-7doiSubjects--Topical Terms:

645254
Hematology.

LC Class. No.: RB45

Dewey Class. No.: 616.15

Hodgkin Lymphoma = A Comprehensive Overview /
LDR:04062nam a22004095i 4500 001 1025182
003 DE-He213
005 20200705003919.0
007 cr nn 008mamaa
008 210318s2020 gw | s |||| 0|eng d
020 $a 9783030324827 $9 978-3-030-32482-7
024 7 $a 10.1007/978-3-030-32482-7 $2 doi
035 $a 978-3-030-32482-7
050 4 $a RB45
072 7 $a MJF $2 bicssc
072 7 $a MED038000 $2 bisacsh
072 7 $a MJF $2 thema
082 0 4 $a 616.15 $2 23
245 1 0 $a Hodgkin Lymphoma $h [electronic resource] : $b A Comprehensive Overview / $c edited by Andreas Engert, Anas Younes.
250 $a 3rd ed. 2020.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a IX, 509 p. 102 illus., 83 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Hematologic Malignancies, $x 2197-9766
505 0 $a Part I: Epidemiology and Pathogenesis -- Epidemiology of Hodgkin Lymphoma -- The role of viruses in the genesis of Hodgkin Lymphoma -- Pathology and molecular pathology of Hodgkin Lymphoma -- Microenvironment, cross-talk and immune escape mechanisms.-What will we learn from Genomics and Proteomics in Hodgkin Lymphoma? -- Part II: Diagnosis and first-line treatment -- Clinical evaluation -- Functional imaging in Hodgkin Lymphoma -- Prognostic factors. - Principles of Radiation Therapy for Hodgkin Lymphoma -- Principles of chemotherapy in Hodgkin Lymphoma -- Treatment of early favorable Hodgkin Lymphoma -- Treatment of early unfavorable Hodgkin Lymphoma -- Treatment of advanced-stage Hodgkin Lymphoma -- Optimizing Decision Making in HL -- Part III: Special clinical situations -- Paediatric/adolescent Hodgkin Lymphoma -- The management of elderly patients with Hodgkin Lymphoma -- Nodular Lymphocyte-Predominant Hodgkin Lymphoma -- The management of Hodgkin Lymphoma during pregnancy -- The management of HIV-Hodgkin Lymphoma -- Part IV: Relapsed and refractory disease -- Relapsed and refractory Hodgkin Lymphoma -- Allogeneic transplantation for relapsed Hodgkin Lymphoma -- Targeting CD30 in Patients with Hodgkin Lymphoma -- Hodgkin Lymphoma and PD-1 blockade -- Other new agents for Hodgkin Lymphoma -- Part V: Survivorship -- Quality of Life in Hodgkin lymphoma -- Second malignancy risk after treatment of Hodgkin Lymphoma -- Cardiovascular and pulmonary late effects -- Gonadal dysfunction and fertility preservation in Hodgkin Lymphoma patients -- Fatigue.
520 $a This book, now in its third edition, examines the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the appropriate management in special clinical circumstances, including in the elderly, pregnant women, and those with nodular lymphocyte-predominant disease (NLPHL). Careful attention is devoted to the emerging individually tailored treatment strategies, including checkpoint inhibition, that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The new edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by key opinion leaders to reflect recent progress in the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma.
650 0 $a Hematology. $3 645254
650 0 $a Oncology . $3 1253469
650 2 4 $a Oncology. $3 593951
700 1 $a Engert, Andreas. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 782074
700 1 $a Younes, Anas. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1066048
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030324810
776 0 8 $i Printed edition: $z 9783030324834
776 0 8 $i Printed edition: $z 9783030324841
830 0 $a Hematologic Malignancies, $x 2197-9766 $3 1253495
856 4 0 $u https://doi.org/10.1007/978-3-030-32482-7
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)